Načítá se...
GLP-1 receptor agonist exenatide restores atypical antipsychotic clozapine treatment-associated glucose dysregulation and damage of pancreatic islet beta cells in mice
BACKGROUND AND AIMS: The aim of this study was to investigate the effect of a glucagon-like peptide-1 receptor agonist (GLP-1RA), exenatide, on clozapine-associated glucose dysregulation in mice. MATERIALS AND METHODS: We randomly separated B6 male mice into four groups (A to D). Mice in groups C an...
Uloženo v:
| Vydáno v: | Toxicol Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5615926/ https://ncbi.nlm.nih.gov/pubmed/28959568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2016.04.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|